By

Gisela Pairo
Patient centricity is at the core of EU-PEARL’s mission. That is why we are engaging with patients from the start to co-design the platform trial framework, thus bringing on board more patient-relevant outcomes. Making clinical trials more efficient and patient friendly can ensure that individuals find the clinical trial that matches their needs, that companies...
Read More
Physician, specialised in internal medicine, infectious diseases and epidemiology/public health. EU-PEARL’s scientific co-coordinator, giving support to Dr Joan Genescà. He is part of the VHIR team. – How and why did you become involved in EU-PEARL? I have been passionately engaged in research ever since the early stages of my career combining my work as...
Read More
EU-PEARL will participate in the Children’s Tumor Foundation (CTF) Annual Conference which will take place online next June 15th and 16th. This global forum focuses on building consensus and advancing translational and clinical research to improve outcomes for patients with neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis. Every year, this event attracts nearly 500...
Read More
On 29 May, EU PEARL launched a call for testimonials to collect feedback on patient’s experience participating in clinical trials. If you have participated in a clinical trial and have feedback to share, you can write to us in 3-5 sentences about your experience. Your testimonial will be shared on the EU PEARL and EPF...
Read More
1 5 6 7

Sign up to stay informed


    We will process your data to deliver our quarterly updates to your inbox. You can view our Privacy Policy here or contact us at info@eu-pearl.eu